Pseudomonas lipopolysaccharide accelerates wound repair via activation of a novel epithelial cell signaling cascade

Journal of Immunology

Volumn 177, Issue 12, 2006, Pages 8693-8700

  Koff, Jonathan L ^a,b   Shao, Matt X G ^a,b   Kim, Sull ^a,b   Ueki, Iris F ^a   Nadel, Jay A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; BACTERIUM LIPOPOLYSACCHARIDE; DUAL OXIDASE 1; EPIDERMAL GROWTH FACTOR RECEPTOR; METALLOPROTEINASE INHIBITOR; NEUTRALIZING ANTIBODY; OXIDOREDUCTASE; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCAVENGER; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ARTICLE; CELL SURFACE; CHRONIC LUNG DISEASE; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PSEUDOMONAS; RECEPTOR UPREGULATION; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT DISEASE; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 33845430467     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.12.8693     Document Type: Article

References (64)

1. Kunzelmann, K., and B. McMorran. 2004. First encounter: how pathogens compromise epithelial transport. Physiology 19: 240-244.
2. Kazmierczak, B. I., K. Mostov, and J. N. Engel. 2001. Interaction of bacterial pathogens with polarized epithelium. Annu. Rev. Microbiol. 55: 407-435.
3. Knowles, M. R., and R. C. Boucher. 2002. Mucus clearance as a primary innate defense mechanism for mammalian airways. J. Clin. Invest. 109: 571-577.
4. Whitsett, J. A. 2002. Intrinsic and innate defenses in the lung: intersection of pathways regulating lung morphogenesis, host defense, and repair. J. Clin. Invest. 109: 565-569.
5. Gibson, R. L., J. L. Burns, and B. W. Ramsey. 2003. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am. J. Respir. Crit. Care Med. 168: 918-951.
6. Barker, A. F. 2002. Bronchiectasis. N. Engl. J. Med. 346: 1383-1384.
7. Sethi, S., N. Evans, B. J. Grant, and T. F. Murphy. 2002. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N. Engl. J. Med. 347: 465-471.
8. Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162: 3749-3752.
9. Medzhitov, R., P. Preston-Hurlburt, and C. A. Janeway, Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397.
10. Akira, S., K. Takeda, and T. Kaisho. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2: 675-680.
11. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
12. Baltimore, R. S., C. D. Christie, and G. I. Smith. 1989. Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis: implications for the pathogenesis of progressive lung deterioration. Am. Rev. Respir. Dis. 140: 1650-1661.
13. Jeffery, P. K. 2001. Remodeling in asthma and chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. 164: S28-S38.
14. Matthay, M. A., J. P. Thiery, F. Lafont, F. Stampfer, and B. Boyer. 1993. Transient effect of epidermal growth factor on the motility of an immortalized mammary epithelial cell line. J. Cell Sci. 106: 869-878.
15. Puddicombe, S. M., R. Polosa, A. Richter, M. T. Krishna, P. H. Howarth, S. T. Holgate, and D. E. Davies. 2000. Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J. 14: 1362-1374.
16. Takeyama, K., K. Dabbagh, H. M. Lee, C. Agusti, J. A. Lausier, I. F. Ueki, K. M. Grattan, and J. A. Nadel. 1999. Epidermal growth factor system regulates mucin production in airways. Proc. Natl. Acad. Sci. USA 96: 3081-3086.
17. Kurahashi, K., O. Kajikawa, T. Sawa, M. Ohara, M. A. Gropper, D. W. Frank, T. R. Martin, and J. P. Wiener-Kronish. 1999. Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J. Clin. Invest. 104: 743-750.
18. Wilson, R., R. B. Dowling, and A. D. Jackson. 1996. The effects of bacterial products on airway cells and their function. Am. J. Respir. Crit. Care Med. 154: S197-S201.
19. Sadikot, R. T., T. S. Blackwell, J. W. Christman, and A. S. Prince. 2005. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am. J. Respir. Crit. Care Med. 171: 1209-1223.
20. De Bentzmann, S., M. Polette, J. M. Zahm, J. Hinnrasky, C. Kileztky, O. Bajolet, J. M. Klossek, A. Filloux, A. Lazdunski, and E. Puchelle. 2000. Pseudomonas aeruginosa virulence factors delay airway epithelial wound repair by altering the actin cytoskeleton and inducing overactivation of epithelial matrix metalloproteinase-2. Lab. Invest. 80: 209-219.
21. Garrity-Ryan, L., S. Shafikhani, P. Balachandran, L. Nguyen, J. Oza, T. Jakobsen, J. Sargent, X. Fang, S. Cordwell, M. A. Matthay, and J. N. Engel. 2004. The ADP ribosyltransferase domain of Pseudomonas aeruginosa ExoT contributes to its biological activities. Infect. Immun. 72: 546-558.
22. Geiser, T. K., B. I. Kazmierczak, L. K. Garrity-Ryan, M. A. Matthay, and J. N. Engel. 2001. Pseudomonas aeruginosa ExoT inhibits in vitro lung epithelial wound repair. Cell. Microbiol. 3: 223-236.
23. Zhang, Y., A. Wolf-Yadlin, P. L. Ross, D. J. Pappin, J. Rush, D. A. Lauffenburger, and F. M. White. 2005. Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules. Mol. Cell. Proteomics 4: 1240-1250.
24. Shao, M. X., and J. A. Nadel. 2005. Dual oxidase 1-dependent MUC5AC mucin expression in cultured human airway epithelial cells. Proc. Natl. Acad. Sci. USA 102: 767-772.
25. Shao, M. X., I. F. Ueki, and J. A. Nadel. 2003. Tumor necrosis factor α-converting enzyme mediates MUC5AC mucin expression in cultured human airway epithelial cells. Proc. Natl. Acad. Sci. USA 100: 11618-11623.
26. Takeyama, K., K. Dabbagh, J. Jeong Shim, T. Dao-Pick, I. F. Ueki, and J. A. Nadel. 2000. Oxidative stress causes mucin synthesis via transactivation of epidermal growth factor receptor: role of neutrophils. J. Immunol. 164: 1546-1552.
27. Takeyama, K., B. Jung, J. J. Shim, P. R. Burgel, T. Dao-Pick, I. F. Ueki, U. Protin, P. Kroschel, and J. A. Nadel. 2001. Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. Am. J. Physiol. 280: L165-L172.
28. Peschon, J. J., J. L. Slack, P. Reddy, K. L. Stocking, S. W. Sunnarborg, D. C. Lee, W. E. Russell, B. J. Castner, R. S. Johnson, J. N. Fitzner, et al. 1998. An essential role for ectodomain shedding in mammalian development. Science 282: 1281-1284.
29. De Deken, X., D. Wang, M. C. Many, S. Costagliola, F. Libert, G. Vassart, J. E. Dumont, and F. Miot. 2000. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J. Biol. Chem. 275: 23227-23233.
30. Geiszt, M., J. Witta, J. Baffi, K. Lekstrom, and T. L. Leto. 2003. Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J. 17: 1502-1504.
31. Suzuki, Y., and R. I. Lehrer. 1980. NAD(P)H oxidase activity in human neutrophils stimulated by phorbol myristate acetate. J. Clin. Invest. 66: 1409-1418.
32. Aksoy, E., M. Goldman, and F. Willems. 2004. Protein kinase Cε: a new target to control inflammation and immune-mediated disorders. Int. J. Biochem. Cell Biol. 36: 183-188.
33. Asehnoune, K., D. Strassheim, S. Mitra, J. Yeol Kim, and E. Abraham. 2005. Involvement of PKCαβ in TLR4 and TLR2 dependent activation of NF-κB. Cell Signal. 17: 385-394.
34. Kim, D. C., S. H. Kim, M. W. Jeong, N. I. Baek, and K. T. Kim. 2005. Effect of rottlerin, a PKC-δ inhibitor, on TLR-4-dependent activation of murine microglia. Biochem. Biophys. Res. Commun. 337: 110-115.
35. Zahm, J. M., M. Chevillard, and E. Puchelle. 1991. Wound repair of human surface respiratory epithelium. Am. J. Respir. Cell Mol. Biol. 5: 242-248.
36. Kheradmand, F., H. G. Folkesson, L. Shum, R. Derynk, R. Pytela, and M. A. Matthay. 1994. Transforming growth factor-α enhances alveolar epithelial cell repair in a new in vitro model. Am. J. Physiol. 267: L728-L738.
37. 4 integrin subunits in corneal epithelium. J. Cell. Biochem. 80: 397-414.
38. Hebda, P. A. 1988. Stimulatory effects of transforming growth factor-β and epidermal growth factor on epidermal cell outgrowth from porcine skin explant cultures. J. Invest. Dermatol. 91: 440-445.
39. Frey, M. R., A. Golovin, and D. B. Polk. 2004. Epidermal growth factor-stimulated intestinal epithelial cell migration requires Src family kinase-dependent p38 MAPK signaling. J. Biol. Chem. 279: 44513-44521.
40. Myhre, G. M., M. Toruner, S. Abraham, and L. J. Egan. 2004. Metalloprotease disintegrin-mediated ectodomain shedding of EGFR ligands promotes intestinal epithelial restitution. Am. J. Physiol 287: G1213-G1219.
41. Block, E. R., A. R. Matela, N. SundarRaj, E. R. Iszkula, and J. K. Klarlund. 2004. Wounding induces motility in sheets of corneal epithelial cells through loss of spatial constraints: role of heparin-binding epidermal growth factor-like growth factor signaling. J. Biol. Chem. 219: 24307-24312.
42. Xu, K. P., Y. Ding, J. Ling, Z. Dong, and F. S. Yu. 2004. Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells. Invest. Ophthalmol. Visual Sci. 45: 813-820.
43. Shirakata, Y., R. Kimura, D. Nanba, R. Iwamoto, S. Tokumaru, C. Morimoto, K. Yokota, M. Nakamura, K. Sayama, E. Mekada, et al. 2005. Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing. J. Cell Sci. 118: 2363-2370.
44. Tokumaru, S., S. Higashiyama, T. Endo, T. Nakagawa, J. I. Miyagawa, K. Yamamori, Y. Hanakawa, H. Ohmoto, K. Yoshino, Y. Shirakata, et al. 2000. Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J. Cell Biol. 151: 209-220.
45. Sunnarborg, S. W., C. L. Hinkle, M. Stevenson, W. E. Russell, C. S. Raska, J. J. Peschon, B. J. Castner, M. J. Gerhart, R. J. Paxton, R. A. Black, and D. C. Lee. 2002. Tumor necrosis factor-α converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J. Biol. Chem. 277: 12838-12845.
46. Mirastschijski, U., C. J. Haaksma, J. J. Tomasek, and M. S. Agren. 2004. Matrix metalloproteinase inhibitor GM 6001 attenuates keratinocyte migration, contraction and myofibroblast formation in skin wounds. Exp. Cell Res. 299: 465-475.
47. Black, R. A., C. T. Rauch, C. J. Kozlosky, J. J. Peschon, J. L. Slack, M. F. Wolfson, B. J. Castner, K. L. Stocking, P. Reddy, S. Srinivasan, et al. 1997. A metalloproteinase disintegrin that releases tumor-necrosis factor-α from cells. Nature 385: 729-733.
48. Elbashir, S. M., J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498.
49. Harborth, J., S. M. Elbashir, K. Bechert, T. Tuschl, and K. Weber. 2001. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J. Cell Sci. 114: 4557-4565.
50. phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269: 131-140.
51. Lambeth, J. D. 2002. Nox/Duox family of nicotinamide adenine dinucleotide (phosphate) oxidases. Curr. Opin. Hematol 9: 11-17.
52. Asehnoune, K., D. Strassheim, S. Mitra, J. Y. Kim, and E. Abraham. 2004. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-κB. J. Immunol. 172: 2522-2529.
53. Park, H. S., H. Y. Jung, E. Y. Park, J. Kim, W. J. Lee, and Y. S. Bae. 2004. Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-κB. J. Immunol. 173: 3589-3593.
54. phox deficiency impairs NF-κB activation and host defense in Pseudomonas pneumonia. J. Immunol. 172: 1801-1808.
55. Greene, C. M., T. P. Carroll, S. G. Smith, C. C. Taggart, J. Devaney, S. Griffin, S. J. O'Neill, and N. G. McElvaney. 2005. TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells. J. Immunol. 174: 1638-1646.
56. Guillot, L., S. Medjane, K. Le-Barillec, V. Balloy, C. Danel, M. Chignard, and M. Si-Tahar. 2004. Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4. J. Biol. Chem. 279: 2712-2718.
57. Sabroe, I., S. K. Dower, and M. K. Whyte. 2005. The role of Toll-like receptors in the regulation of neutrophil migration, activation, and apoptosis. Clin. Infect. Dis. 7(Suppl. 41): S421-S426.
58. Sabroe, I., L. R. Prince, E. C. Jones, M. J. Horsburgh, S. J. Foster, S. N. Vogel, S. K. Dower, and M. K. Whyte. 2003. Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span. J. Immunol. 170: 5268-5275.
59. Houtmeyers, E., R. Gosselink, G. Gayan-Ramirez, and M. Decramer. 1999. Regulation of mucociliary clearance in health and disease. Eur. Respir. J. 13: 1177-1188.
60. Richter, A., R. A. O'Donnell, R. M. Powell, M. W. Sanders, S. T. Holgate, R. Djukanovic, and D. E. Davies. 2002. Autocrine ligands for the epidermal growth factor receptor mediate interleukin-8 release from bronchial epithelial cells in response to cigarette smoke. Am. J. Respir. Cell Mol. Biol. 27: 85-90.
61. Jorens, P. G., J. B. Richman-Eisenstat, B. P. Housset, P. D. Graf, I. F. Ueki, J. Olesch, and J. A. Nadel. 1992. Interleukin-8 induces neutrophil accumulation but not protease secretion in the canine trachea. Am. J. Physiol. 263: L708-L713.
62. Yoshimura, T., K. Matsushima, S. Tanaka, E. A. Robinson, E. Appella, J. J. Oppenheim, and E. J. Leonard. 1987. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl Acad. Sci. USA 84: 9233-9237.
63. Sorensen, O. E., D. R. Thapa, A. Rosenthal, L. Liu, A. A. Roberts, and T. Ganz. 2005. Differential regulation of β-defensin expression in human skin by microbial stimuli. J. Immunol. 174: 4870-4879.
64. Tjabringa, G. S., J. Aarbiou, D. K. Ninaber, J. W. Drijfhout, O. E. Sorensen, N. Borregaard, K. F. Rabe, and P. S. Hiemstra. 2003. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J. Immunol. 171: 6690-5696.